Effect Of Celecoxib On Hip Osteoarthritis (OA) Progression
Clinical trial NCT00163241 · TERMINATED
Trial details
- NCT number
- NCT00163241
- Sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2004-06-01
- Enrollment
- 666
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.